Kazia Therapeutics (KZIA) Shares Outstanding (Weighted Average) (2017 - 2025)

Kazia Therapeutics' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $518.4 million for Q2 2025.

  • For Q2 2025, Shares Outstanding (Weighted Average) rose 673.91% year-over-year to $518.4 million; the TTM value through Jun 2025 reached $518.4 million, up 673.91%, while the annual FY2025 figure was $518.4 million, 673.91% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $518.4 million in Q2 2025 per KZIA's latest filing, up from $67.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $518.4 million in Q2 2025 to a low of $67.0 million in Q2 2024.
  • Average Shares Outstanding (Weighted Average) over 4 years is $209.3 million, with a median of $125.9 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): tumbled 56.05% in 2024, then soared 673.91% in 2025.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $99.4 million in 2022, then skyrocketed by 53.35% to $152.4 million in 2023, then crashed by 56.05% to $67.0 million in 2024, then skyrocketed by 673.91% to $518.4 million in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Shares Outstanding (Weighted Average) are $518.4 million (Q2 2025), $67.0 million (Q2 2024), and $152.4 million (Q2 2023).